Somatostatin Inhibits Cell Migration and Delays Wound Healing in Human Keratinocytes
Author Information
Author(s): Matthias Vockel, Simone Pollok, Ute Breitenbach, Ina Ridderbusch, Hans-Jürgen Kreienkamp, Johanna M. Brandner
Primary Institution: University Hospital Hamburg-Eppendorf
Hypothesis
Somatostatin (SST) negatively regulates keratinocyte migration and proliferation, affecting wound healing.
Conclusion
Somatostatin significantly inhibits keratinocyte migration and reduces cell counts, leading to delayed wound healing.
Supporting Evidence
- Somatostatin treatment led to a significant reduction in keratinocyte cell counts.
- Cell migration was significantly delayed in the presence of somatostatin.
- Somatostatin did not affect apoptosis or necrosis in keratinocytes.
- All five somatostatin receptor subtypes were expressed in human keratinocytes.
- Somatostatin inhibited Rac1 activity, which is important for cell migration.
- Delayed re-epithelialization was observed in an ex vivo wound healing model treated with somatostatin.
Takeaway
Somatostatin is like a stop sign for skin cells, telling them to slow down their movement and growth, which can make it harder for wounds to heal.
Methodology
The study used receptor-specific agonists to analyze the effects of somatostatin on keratinocyte migration and proliferation in vitro and in an ex vivo wound healing model.
Potential Biases
Potential bias due to the involvement of authors affiliated with Beiersdorf AG, which funded the research.
Limitations
The study primarily focused on the effects of somatostatin in a controlled laboratory setting, which may not fully replicate in vivo conditions.
Participant Demographics
Human keratinocytes obtained from neonatal foreskin samples.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website